Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice

59 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds